Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Preferred Shares (2023 - 2025)

INVO Fertility has reported Preferred Shares over the past 3 years, most recently at $8.9 million for Q3 2025.

  • Quarterly Preferred Shares rose 47.96% to $8.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Sep 2025, up 47.96% year-over-year, with the annual reading at $30.4 million for FY2024, 406.25% up from the prior year.
  • Preferred Shares was $8.9 million for Q3 2025 at INVO Fertility, down from $10.1 million in the prior quarter.
  • Over five years, Preferred Shares peaked at $30.4 million in Q4 2024 and troughed at $500000.0 in Q1 2024.
  • The 3-year median for Preferred Shares is $7.4 million (2023), against an average of $11.7 million.
  • The largest YoY upside for Preferred Shares was 5975.0% in 2025 against a maximum downside of 47.96% in 2025.
  • A 3-year view of Preferred Shares shows it stood at $6.0 million in 2023, then skyrocketed by 406.25% to $30.4 million in 2024, then tumbled by 70.77% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Preferred Shares are $8.9 million (Q3 2025), $10.1 million (Q2 2025), and $30.4 million (Q1 2025).